The RETIPATCH project aims to develop a new “tamponade agent” to be used at the end of vitrectomies in cases of retinal detachment. The project is made up of researchers from the Ophthalmology Department of the Germans Trias i Pujol Health Sciences Research Institute Foundation (IGTP) and by the IQS GEMAT (Materials Engineering Group) research group, led by Dr. Salvador Borrós and Dra. Cristina Fornaguera. ETIPATCH is part of the projects that make up the CaixaImpulse Validate 2019 program, which seeks to transfer to society the results of innovative research projects in the field of health and medical sciences.
ホルヘ・ラシェラス（Jorge Lasheras）がキャピタルラジオで、日本の選挙後の投資機会を分析。CEJEがアジア諸国の選挙後の日本における投資機会を分析。
最近日本で行われた選挙は、重要な経済・地
